Duloxetine Approved In EU For Stress Urinary Incontinence
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly and marketing partner Boehringer Ingelheim plan to launch duloxetine under the trade name Yentreve by year-end in the European Union. The NDA for Yentreve is pending at FDA.